Paradigm Biopharmaceuticals (ASX: PAR) Share Price

PAR

$0.15▲+3.45%

$65.0MRank #946 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$65.0M

Volume

1.2M

P/E Ratio

-1.51

EPS

-$0.0562

Dividend Yield

0.00%

52-Week High

$0.48

52-Week Low

$0.135

Beta

-0.018

Paradigm Biopharmaceuticals (ASX: PAR) is an Australian-listed company in the Healthcare sector with a market capitalisation of $65.0M and the 946th-largest security on the ASX by market capitalisation. The PAR share price is $0.15, up 3.45% today and down 50.17% over the past 12 months. Shares have traded between $0.135 and $0.48 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Paradigm Biopharmaceuticals reported revenue of $25,150 and a net loss of $23.2M.

Charts

$0.15

24H Range

$0.145

$0.155

52-Week Range

$0.135

$0.48

About Paradigm Biopharmaceuticals Limited

Based in Melbourne, Australia, Paradigm Biopharmaceuticals Limited specializes in the repurposing of existing drugs, developing therapeutic solutions for human health. A central offering is an injectable formulation of pentosan polysulfate sodium, currently undergoing development for the treatment of conditions including osteoarthritis, mucopolysaccharidosis, Ross River virus, chikungunya, and acute respiratory distress syndrome. This company commenced operations in 2014.

IPO Date

19 Aug 2015

CEO

Paul John Rennie

Website

paradigmbiopharma.com

Key Financial Data

Revenue (Quarterly)	$25,150
Net Income (Quarterly)	$-23.2M
Total Assets	$23.2M
Total Debt	$1.0M
Free Cash Flow	$0
Return on Equity	-387.56%
Profit Margin	-92423.02%
Operating Margin	-86793.89%

PAR Frequently Asked Questions

What is the Paradigm Biopharmaceuticals (ASX: PAR) share price?

The PAR share price is $0.15, up 3.45% for the day, based on the latest available ASX market data.

What is Paradigm Biopharmaceuticals's market capitalisation?

Paradigm Biopharmaceuticals has a market capitalisation of $65.0M, making it the 946th-largest security listed on the ASX.

Does Paradigm Biopharmaceuticals pay a dividend?

PAR does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Paradigm Biopharmaceuticals profitable?

In its most recent reported period (ending 31 Dec 2025), PAR reported revenue of $25,150 and a net loss of $23.2M.

How many PAR shares are on issue?

Paradigm Biopharmaceuticals has approximately 433,387,380 shares on issue, based on its market capitalisation of $65.0M and current share price.

What sector is Paradigm Biopharmaceuticals in?

Paradigm Biopharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Paradigm Biopharmaceuticals list on the ASX?

Paradigm Biopharmaceuticals listed on the Australian Securities Exchange on 19 Aug 2015.

Latest News

When Will Paradigm Biopharmaceuticals Limited (ASX:PAR) Turn A Profit?

simplywall.st8 Apr 2026

When Will Paradigm Biopharmaceuticals Limited (ASX:PAR) Turn A Profit? simplywall.st

Market Sentiment Around Loss-Making Paradigm Biopharmaceuticals Limited (ASX:PAR)

Yahoo Finance21 May 2026

Market Sentiment Around Loss-Making Paradigm Biopharmaceuticals Limited (ASX:PAR) Yahoo Finance

Paradigm Biopharmaceuticals raises $14M in upsized placement, launches SPP | ASX:PAR

Proactive financial news27 Apr 2026

Paradigm Biopharmaceuticals raises $14M in upsized placement, launches SPP | ASX:PAR Proactive financial news

Paradigm Biopharmaceuticals Limited (ASX: PAR) - Share Price

intelligentinvestor.com.au21 July 2025

Paradigm Biopharmaceuticals Limited (ASX: PAR) - Share Price intelligentinvestor.com.au

Paradigm Biopharmaceuticals Limited's (ASX:PAR) Profit Outlook

Yahoo Finance1 Oct 2025

Paradigm Biopharmaceuticals Limited's (ASX:PAR) Profit Outlook Yahoo Finance

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
PEBPacific Edge Limited	$304.7M	$0.26	-2.67	0.00%	▲+4.00%
SPLStarpharma Holdings Limited	$286.2M	$0.68	27.58	0.00%	▲+1.49%
ONEOneview Healthcare PLC	$149.6M	$0.17	-9.06	0.00%	▲+4.62%
EMVEMVision Medical Devices Ltd	$145.9M	$1.57	-10.00	0.00%	▼-1.88%
RCERecce Pharmaceuticals Ltd	$144.6M	$0.50	-2.84	0.00%	▲+2.04%
AVHAVITA Medical, Inc.	$134.2M	$1.08	-26.62	0.00%	▼-5.68%
ACWActinogen Medical Limited	$122.0M	$0.034	-4.28	0.00%	–+0.00%
NYRNyrada Inc.	$87.9M	$0.44	-20.63	0.00%	▼-2.22%

ETFs That Hold PAR

PAR is held by 2 ASX-listed funds tracked on this site. The largest allocation is in Vanguard MSCI International Small Companies Index ETF (ASX: VISM) at 0.01% of its portfolio.

Fund	Portfolio Weight	Fund Size
VISMVanguard MSCI International Small Companies Index ETF	0.01%	$906.8M
VTSVanguard U.S. Total Market Shares Index ETF	0.00%	$9.53B

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.145	$0.155	$0.145	$0.147	1.1M	▲+1.38%
11 June 2026	$0.14	$0.145	$0.14	$0.145	1.6M	▲+3.57%
10 June 2026	$0.142	$0.145	$0.135	$0.14	1.6M	▼-1.41%
9 June 2026	$0.142	$0.145	$0.14	$0.142	1.4M	▼-2.07%
8 June 2026	$0.145	$0.147	$0.145	$0.145	1.7M	–+0.00%
5 June 2026	$0.145	$0.147	$0.145	$0.145	1.3M	–+0.00%
4 June 2026	$0.155	$0.16	$0.145	$0.145	5.1M	▼-9.38%
3 June 2026	$0.155	$0.165	$0.155	$0.16	2.3M	–+0.00%
2 June 2026	$0.16	$0.16	$0.15	$0.16	3.4M	–+0.00%
1 June 2026	$0.165	$0.165	$0.152	$0.16	3.8M	▼-3.03%
29 May 2026	$0.165	$0.17	$0.16	$0.165	1.2M	–+0.00%
28 May 2026	$0.17	$0.17	$0.165	$0.165	840K	▼-2.94%
27 May 2026	$0.175	$0.175	$0.165	$0.17	995K	▼-2.86%
26 May 2026	$0.18	$0.18	$0.175	$0.175	314K	▼-1.13%
25 May 2026	$0.175	$0.185	$0.175	$0.177	1.1M	▲+1.14%
22 May 2026	$0.165	$0.18	$0.165	$0.175	1.3M	▲+8.02%
21 May 2026	$0.165	$0.17	$0.162	$0.162	661K	–+0.00%
20 May 2026	$0.17	$0.17	$0.16	$0.162	718K	▼-2.99%
19 May 2026	$0.17	$0.175	$0.16	$0.167	1.3M	▼-1.76%
18 May 2026	$0.17	$0.175	$0.17	$0.17	774K	–+0.00%
15 May 2026	$0.175	$0.18	$0.17	$0.17	951K	▼-2.86%
14 May 2026	$0.18	$0.18	$0.17	$0.175	1.3M	–+0.00%
13 May 2026	$0.18	$0.18	$0.175	$0.175	347K	▼-1.13%
12 May 2026	$0.18	$0.185	$0.175	$0.177	873K	▼-1.67%
11 May 2026	$0.185	$0.185	$0.175	$0.18	2.1M	▼-2.70%
8 May 2026	$0.175	$0.185	$0.175	$0.185	1.1M	▲+7.56%
7 May 2026	$0.18	$0.18	$0.172	$0.172	1.3M	▼-2.82%
6 May 2026	$0.175	$0.18	$0.172	$0.177	2M	▲+2.91%
5 May 2026	$0.17	$0.175	$0.165	$0.172	2M	▲+6.17%
4 May 2026	$0.16	$0.175	$0.16	$0.162	3.2M	▲+3.18%

About Paradigm Biopharmaceuticals Limited

IPO Date

19 Aug 2015

CEO

Paul John Rennie

Website

paradigmbiopharma.com

PAR Frequently Asked Questions

What is the Paradigm Biopharmaceuticals (ASX: PAR) share price?

The PAR share price is $0.15, up 3.45% for the day, based on the latest available ASX market data.

What is Paradigm Biopharmaceuticals's market capitalisation?

Paradigm Biopharmaceuticals has a market capitalisation of $65.0M, making it the 946th-largest security listed on the ASX.

Does Paradigm Biopharmaceuticals pay a dividend?

PAR does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Paradigm Biopharmaceuticals profitable?

In its most recent reported period (ending 31 Dec 2025), PAR reported revenue of $25,150 and a net loss of $23.2M.

How many PAR shares are on issue?

Paradigm Biopharmaceuticals has approximately 433,387,380 shares on issue, based on its market capitalisation of $65.0M and current share price.

What sector is Paradigm Biopharmaceuticals in?

Paradigm Biopharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Paradigm Biopharmaceuticals list on the ASX?

Paradigm Biopharmaceuticals listed on the Australian Securities Exchange on 19 Aug 2015.

Company

Market Cap

Price

P/E

Div Yield

1D Change

PEBPacific Edge Limited

$304.7M

$0.26

-2.67

0.00%

▲+4.00%

SPLStarpharma Holdings Limited

$286.2M

$0.68

27.58

0.00%

▲+1.49%

ONEOneview Healthcare PLC

$149.6M

$0.17

-9.06

0.00%

▲+4.62%

EMVEMVision Medical Devices Ltd

$145.9M

$1.57

-10.00

0.00%

▼-1.88%

RCERecce Pharmaceuticals Ltd

$144.6M

$0.50

-2.84

0.00%

▲+2.04%

AVHAVITA Medical, Inc.

$134.2M

$1.08

-26.62

0.00%

▼-5.68%

ACWActinogen Medical Limited

$122.0M

$0.034

-4.28

0.00%

–+0.00%

NYRNyrada Inc.

$87.9M

$0.44

-20.63

0.00%

▼-2.22%

ETFs That Hold PAR

PAR is held by 2 ASX-listed funds tracked on this site. The largest allocation is in Vanguard MSCI International Small Companies Index ETF (ASX: VISM) at 0.01% of its portfolio.

Fund

Portfolio Weight

Fund Size

VISMVanguard MSCI International Small Companies Index ETF

0.01%

$906.8M

VTSVanguard U.S. Total Market Shares Index ETF

0.00%

$9.53B

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.145	$0.155	$0.145	$0.147	1.1M	▲+1.38%
11 June 2026	$0.14	$0.145	$0.14	$0.145	1.6M	▲+3.57%
10 June 2026	$0.142	$0.145	$0.135	$0.14	1.6M	▼-1.41%
9 June 2026	$0.142	$0.145	$0.14	$0.142	1.4M	▼-2.07%
8 June 2026	$0.145	$0.147	$0.145	$0.145	1.7M	–+0.00%
5 June 2026	$0.145	$0.147	$0.145	$0.145	1.3M	–+0.00%
4 June 2026	$0.155	$0.16	$0.145	$0.145	5.1M	▼-9.38%
3 June 2026	$0.155	$0.165	$0.155	$0.16	2.3M	–+0.00%
2 June 2026	$0.16	$0.16	$0.15	$0.16	3.4M	–+0.00%
1 June 2026	$0.165	$0.165	$0.152	$0.16	3.8M	▼-3.03%
29 May 2026	$0.165	$0.17	$0.16	$0.165	1.2M	–+0.00%
28 May 2026	$0.17	$0.17	$0.165	$0.165	840K	▼-2.94%
27 May 2026	$0.175	$0.175	$0.165	$0.17	995K	▼-2.86%
26 May 2026	$0.18	$0.18	$0.175	$0.175	314K	▼-1.13%
25 May 2026	$0.175	$0.185	$0.175	$0.177	1.1M	▲+1.14%
22 May 2026	$0.165	$0.18	$0.165	$0.175	1.3M	▲+8.02%
21 May 2026	$0.165	$0.17	$0.162	$0.162	661K	–+0.00%
20 May 2026	$0.17	$0.17	$0.16	$0.162	718K	▼-2.99%
19 May 2026	$0.17	$0.175	$0.16	$0.167	1.3M	▼-1.76%
18 May 2026	$0.17	$0.175	$0.17	$0.17	774K	–+0.00%
15 May 2026	$0.175	$0.18	$0.17	$0.17	951K	▼-2.86%
14 May 2026	$0.18	$0.18	$0.17	$0.175	1.3M	–+0.00%
13 May 2026	$0.18	$0.18	$0.175	$0.175	347K	▼-1.13%
12 May 2026	$0.18	$0.185	$0.175	$0.177	873K	▼-1.67%
11 May 2026	$0.185	$0.185	$0.175	$0.18	2.1M	▼-2.70%
8 May 2026	$0.175	$0.185	$0.175	$0.185	1.1M	▲+7.56%
7 May 2026	$0.18	$0.18	$0.172	$0.172	1.3M	▼-2.82%
6 May 2026	$0.175	$0.18	$0.172	$0.177	2M	▲+2.91%
5 May 2026	$0.17	$0.175	$0.165	$0.172	2M	▲+6.17%
4 May 2026	$0.16	$0.175	$0.16	$0.162	3.2M	▲+3.18%